这里有精品在线,中文有码第八页

AstraZeneca Full Year 2025 Financial Report AstraZeneca AstraZeneca reports 2025 revenue of $58.7B, led by strong oncology growth, a record China performance, and a catalyst-rich pipeline driving momentum into 2026 and beyond.
2025 H1 Global Pharma Earnings Panorama Financial statements A comprehensive analysis of global pharma earnings in H1 2025, highlighting innovation-driven growth, key players like Novartis, Novo Nordisk, AstraZeneca, Sanofi, and BeiGene, and trends shaping the industry’s future.
AstraZeneca 2025 H1 Results AstraZeneca AstraZeneca reports strong H1 2025 results with $28B in revenue. Oncology leads growth, driven by Enhertu, Tagrisso, and Truqap. R&D up 16%. Strong gains in CVRM, R&I, and rare diseases.
ASCO 2025: Opening a New Era of "Cancer Eradication" ASCO Discover the latest breakthroughs from ASCO 2025, including innovative cancer treatments, immunotherapy advances, bispecific antibodies, and promising breast cancer therapies shaping the future of oncology.
Carbogen Invests $31M to Expand ADC Linker Production in Switzerland Carbogen AMCIS Swiss CDMO Carbogen AMCIS, in partnership with a Japanese firm, is investing $31 million to expand its ADC linker production capabilities at two Swiss sites, with completion expected by 2027.
ASCO 2025: AstraZeneca's Breakthrough Innovations in Cancer Treatment Leading Global Oncology Advances ASCO Discover AstraZeneca’s groundbreaking cancer research at ASCO 2025, featuring innovative therapies in breast, lung, and digestive cancers. Leading global oncology with advanced treatments and strategic local-global integration.
Zentiva to Launch eGERD Drug Across Europe AstraZeneca Zentiva signs €220M deal with Cinclus Pharma to commercialize linaprazan glurate for eGERD treatment across Europe. The partnership marks Zentiva’s shift into specialty medicines.
AstraZeneca's Q1 2025 Financial report Market Trend AstraZeneca's Q1 2025 revenue rose 10% to $13.59B, with strong growth in oncology and China contributing $1.8B. CEO highlights rich pipeline, U.S. expansion, and 2030 $80B revenue goal.
Top 10 Oncology Products by Global Sales in 2024 Oncology Explore the top 10 global oncology drugs of 2024 by sales. Discover leading therapies like Keytruda and Darzalex, modality trends, solid vs. blood tumor market insights, and the growing role of cell and gene therapies.
Nuclear Medicine Titans: The Battle in a $10 Billion Market Bayer Explore how pharma giants like Novartis, Bayer, AstraZeneca, BMS, and Eli Lilly are battling for dominance in the booming $10B radiopharmaceutical market with cutting-edge therapies and strategic acquisitions.

<Pre12 3 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水